References
- Nashan, B.; Cole, E.; Levy, G.; Thervet, E. Clinical validation studies of Neoral C2 monitoring: a review. Transplantation 2002, 73 (9), 3–11. [CSA]
- Shidban, H.; Mendez, R. Cyclosporine and tacrolimus. In Textbook of Nephrology, 4th Ed.; Massry, S G., Glassock, R J., Eds.; Lippincott Williams and Willkins: Philadelphia, 2001; 1627–1636.
- Levy, G A. C2 monitoring strategy for optimizing cyclosporine immunosuppression from Neoral formulation. BioDrugs 2001, 15, 279–290. [PUBMED], [INFOTRIEVE], [CSA]
- Kahan, B D. Overview: individualization of cyclosporine therapy using pharmacokinetic and pharmocodynamic parameters. Transplantation 1985, 40, 457–476. [PUBMED], [INFOTRIEVE]
- Lindholm, A.; Kahan, B D. Influence of cyclosporine pharmacokinetics, trough concentration, and AUC monitoring on outcomes after kidney transplantation. Clin. Pharmacol. Ther. 1993, 54, 205–218. [PUBMED], [INFOTRIEVE]
- Kahan, B D.; Welsh, M.; Schoenberg, L. Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic allograft rejection. Transplantation 1996, 62, 599–606. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thervet, E.; Pfeffer, P.; Scolari, M P.; Toselli, L.; Pallardo, L M.; Chadban, S.; Pilmore, H.; Connoly, J.; Buchler, M. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Transplantation 2003, 76 (6), 903–908. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Santana, A.; Guerra, J.; Milhomens, C.; Neves, F.; Prata, M M. C0/C2 cyclosporine levels monitoring in renal transplantation. Transplant. Proc. 2003, 35, 1072–1073. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ojo, A O.; Hanson, J A.; Wolfe, R A. Long-term survival in renal transplant recipients with graft function. Kidney Int. 2000, 57, 307. [PUBMED], [INFOTRIEVE], [CROSSREF]